[Bovine uterine diseases: Aspects of microbiology, molecular biology, and immunology]
Postpartum uterine diseases, such as puerperal metrity and clinical endometritis can affect more than 40% of cows in dairy farms. Whatever their severity, these diseases are one of the main reasons for fertility loyalty, causing declines in the productivity of dairy cows and therefore leading to economic losses. Although uterine diseases have been the subject of scientific discussion for many years, but it was not possible to agree on uniform definitions for different types of events. Including technical innovations and testing procedures, enormous scientific progress and more in-depth knowledge of physiology as well as pathological mechanisms have been achieved. Bovine metris and endometritis can be considered multifactorial diseases caused by a combination of microbial infection, immune system dysregulation and additional risk factors.
These interactions were analyzed on microbial and molecular biological levels as well as the use of bioinformatics and molecular genetics. As a result, new species of bacteria and inflammatory mediators possibly contribute to the development of uterine diseases have recently been described. In addition, metabolic and genetic risk factors and roles due to fertility deficiency have been evaluated. In conclusion, it was possible to identify new approaches for possible therapeutic and preventive methods, of which a subset can already be implemented in a daily practical routine. This article provides an overview of recent scientific results for bovine metritis and endometritis with a focus on microbial, microbiological and immunological studies.
Comparison of student performances by evaluation through a structured practical examination objective with respect to the conventional method of the second year of MBB students in microbiology
Introduction: The structured practical examination (OSPE) is a complete evaluation tool. We wanted to improve our evaluation methods and make it a more skill-based assessment. Thus, this study was designed to compare the effectiveness of the practical review of the structured objectives with that of the conventional practical examination.
Methods: This interventional study was conducted in the Atciimsh Microbiology Department, Lucknow over six months from October 2019 to March 20, 2019. A hundred MBB students of the year were registered. Students were divided into two offulty groups for the conventional review group (controls) and the OSPE group. The first day, the cases appeared for the OSPE while the conventional examination checks. On the second day, the groups were crossed. Students appearing for the Ospewere evaluated by their scores in different stations. The feedback forms with a pre-tutored questionnaire were given to students and examiners after OSPE two days to record their perceptions. Finally, students’ scores have been tabulated and compared. Microsoft Excel and SPSS were used for data analysis. The data were presented in percentages, average and standard deviation. The T test student was used and the meaning has been verified using the value p <0.05.
Results: Overall, in the OSPE, students marked higher and the result was statistically significant. The proportion of students in the upper brand range was more for OSPE Typethat for the conventional method. The difference was statistically significant (p <0.001) .Feedback taken from examiners as well as students in the form of remote-controlled questionnaire to analyze their perceptions was very encouraging.
Conclusions: OSPE is a complete evaluation modality for the practical assessment of MBBS students. OSPE has been an effective tool that improved the forms of microbiology students.
Anatomical graduate in the microbiology of the merger of the spine infection and resistance to surgical antimicrobial prophylaxis
Study design: Hospital retrospective study-register.
Objective: To characterize the microbial epidemiology of surgical site infection (SSI) in the surgery of the vertebral column melting ad the charge of the standard surgical antibiotic prophylaxis resistance.
Summary of basic data: SSI persists as a state-of-the-art complication of spine melting surgery despite the growth of improved recovery programs and improvements in other surgical measurements. Improved understanding of SSI microbiology and common mechanisms for current prevention strategies are required to inform the development of new prevention approaches relevant to modern surgical practice.
Methods: The melting cases of the spine carried out at a single reference center between January 2011 and June 2019 were reviewed and the SSI cases meeting the national health care system criteria were identified. Using microbiological and procedural data for each case, we analyzed the anatomical distribution of pathogens, their differential time on presentation and correlation with staphylococcus filtering results resistant to methicillin. The susceptibility of isolates grown from each infection has been compared to the spectrum of the surgical antibiotic prophylaxis administered during the index procedure on a case-by-case basis. The susceptibility to alternate prophylactic agents has also been modeled.
Results: Of 6727 cases, 351 infections took place within 90 days. An anatomical gradient of the microbiology of SSI has been observed on the length of the back, passing from the cutaneous flora (gram-positive) in the cervical column with the enteric flora (gram-negative / anaerobic) in the Lumbosacrale region (coefficient of Correlation 0.94, p <0.001). The majority (57.5%) of infections were resistant to prophylaxis administered during the proceedings. Cephalosporin-resistant gram-negative infection was common at the LUMBOSACRAL levels and unsecured methicillin resistance was common at the cervical levels.
Trimethoprim |
|||
B2057-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 40 |
Description: bacteriostatic antibiotic |
Trimethoprim |
|||
B2057-50 | ApexBio | 50 mg | EUR 153.6 |
Description: Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections. |
Trimethoprim |
|||
B2057-5000 | ApexBio | 5g | EUR 38 |
Description: bacteriostatic antibiotic |
Trimethoprim |
|||
B2057-S | ApexBio | Evaluation Sample | EUR 22 |
Description: bacteriostatic antibiotic |
Trimethoprim |
|||
AT176 | Unibiotest | 1mg | EUR 1641.6 |
Trimethoprim |
|||
AT224 | Unibiotest | 1mg | EUR 1336.8 |
Trimethoprim |
|||
AG176 | Unibiotest | 1 mg | EUR 627.6 |
Trimethoprim |
|||
AG224 | Unibiotest | 1 mg | EUR 627.6 |
Trimethoprim |
|||
HY-B0510 | MedChemExpress | 10mM/1mL | EUR 135.6 |
Trimethoprim |
|||
GA3656-1 | Glentham Life Sciences | 1 | EUR 21.4 |
Trimethoprim |
|||
GA3656-10 | Glentham Life Sciences | 10 | EUR 75.2 |
Trimethoprim |
|||
GA3656-100 | Glentham Life Sciences | 100 | EUR 316.4 |
Trimethoprim |
|||
GA3656-100G | Glentham Life Sciences | 100 g | EUR 418.8 |
Trimethoprim |
|||
GA3656-10G | Glentham Life Sciences | 10 g | EUR 127.2 |
Trimethoprim |
|||
GA3656-1G | Glentham Life Sciences | 1 g | EUR 62.4 |
Trimethoprim |
|||
GA3656-25 | Glentham Life Sciences | 25 | EUR 126.5 |
Trimethoprim |
|||
GA3656-25G | Glentham Life Sciences | 25 g | EUR 189.6 |
Trimethoprim |
|||
GA3656-5 | Glentham Life Sciences | 5 | EUR 47.4 |
Trimethoprim |
|||
GA3656-50 | Glentham Life Sciences | 50 | EUR 197.7 |
Trimethoprim |
|||
GA3656-50G | Glentham Life Sciences | 50 g | EUR 274.8 |
Trimethoprim |
|||
GA3656-5G | Glentham Life Sciences | 5 g | EUR 93.6 |
Trimethoprim |
|||
PCT1137-25G | EWC Diagnostics | 1 unit | EUR 46.32 |
Description: Trimethoprim |
Trimethoprim |
|||
PCT1137-5G | EWC Diagnostics | 1 unit | EUR 10.29 |
Description: Trimethoprim |
Trimethoprim |
|||
MD059-1PK | EWC Diagnostics | 1 unit | Ask for price |
Description: Trimethoprim |
Trimethoprim |
|||
CMS216-5G | EWC Diagnostics | 1 unit | EUR 10.02 |
Description: Trimethoprim |
Trimethoprim |
|||
T011-100G | TOKU-E | 100 g | EUR 722.23 |
Description: C14H18N4O3 |
Trimethoprim |
|||
T011-25G | TOKU-E | 25 g | EUR 225.57 |
Description: C14H18N4O3 |
Trimethoprim |
|||
T011-5G | TOKU-E | 5 g | EUR 56.65 |
Description: C14H18N4O3 |
Trimethoprim |
|||
T1153-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Trimethoprim |
Trimethoprim |
|||
T1153-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Trimethoprim |
Trimethoprim |
|||
T1153-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trimethoprim |
Trimethoprim |
|||
T1153-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trimethoprim |
Trimethoprim |
|||
T1153-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trimethoprim |
Trimethoprim |
|||
T795615 | Toronto Research Chemicals | 10g | EUR 68 |
Description: 738-70-5 |
Trimethoprim-13C3 |
|||
T795616 | Toronto Research Chemicals | 0.5mg | EUR 3577 |
Description: 1189970-95-3 |
Trimethoprim-15N3 |
|||
T795619 | Toronto Research Chemicals | 100mg | EUR 17000 |
Trimethoprim [BSA] |
|||
DAGA-036B | Creative Diagnostics | 1mg | EUR 998.4 |
Trimethoprim [KLH] |
|||
DAGA-039K | Creative Diagnostics | 1mg | EUR 1326 |
Trimethoprim (HRP) |
|||
abx284048-100g | Abbexa | 100 µg | Ask for price |
Trimethoprim (HRP) |
|||
abx284048-20g | Abbexa | 20 µg | EUR 187.5 |
Trimethoprim (HRP) |
|||
abx284048-50g | Abbexa | 50 µg | Ask for price |
Trimethoprim [OVA] |
|||
DAGA-036O | Creative Diagnostics | 1 mg | EUR 1200 |
Description: Synthetic |
Trimethoprim-d3 |
|||
T795618 | Toronto Research Chemicals | 10mg | EUR 224 |
Description: 1189923-38-3 |
Trimethoprim-HRP |
|||
80-1318 | Fitzgerald | 500 ul | EUR 111 |
Description: Trimethoprim Conjugate for use in immunoassays |
Trimethoprim Lactate |
|||
B1539-1000 | Biovision | each | EUR 574.8 |
Trimethoprim Lactate |
|||
B1539-250 | Biovision | each | EUR 210 |
Trimethoprim sulfate |
|||
GW9332-100 | Glentham Life Sciences | 100 | EUR 511.3 |
Trimethoprim sulfate |
|||
GW9332-25 | Glentham Life Sciences | 25 | EUR 196.1 |
Trimethoprim lactate |
|||
T39862-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Trimethoprim lactate |
Trimethoprim lactate |
|||
T39862-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Trimethoprim lactate |
Trimethoprim lactate |
|||
T39862-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trimethoprim lactate |
Trimethoprim lactate |
|||
T39862-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trimethoprim lactate |
Trimethoprim lactate |
|||
T39862-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trimethoprim lactate |
Trimethoprim Lactate |
|||
T012-1G | TOKU-E | 1 g | EUR 69.46 |
Description: C14H18N4O3 • C3H6O3 |
Trimethoprim Lactate |
|||
T012-250MG | TOKU-E | 250 mg | EUR 306 |
Trimethoprim antibody |
|||
20-1154 | Fitzgerald | 1mg | EUR 633 |
Description: Sheep polyclonal Trimethoprim antibody |
Trimethoprim Antibody |
|||
abx342355-100l | Abbexa | 100 µl | EUR 2137.5 |
Trimethoprim Antibody |
|||
abx342355-50l | Abbexa | 50 µl | EUR 700 |
Trimethoprim (2.5 mcg) |
|||
SD161-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Trimethoprim (2.5 mcg) |
Trimethoprim-cysteine |
|||
T797530 | Toronto Research Chemicals | 25mg | EUR 3000 |
Trimethoprim (free base) |
|||
318953 | MedKoo Biosciences | 1.0g | EUR 150 |
Trimethoprim ELISA Kit |
|||
DEIA037 | Creative Diagnostics | 96T | EUR 1388.4 |
Description: The Trimethoprim ELISA Test Kit is a competitive enzyme immunoassay for the quantitative analysis of Trimethoprim in honey. |
Trimethoprim 3-oxide |
|||
HY-100645 | MedChemExpress | 5mg | EUR 404.4 |
Trimethoprim N-oxide |
|||
T19592-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Trimethoprim N-oxide |
Trimethoprim N-oxide |
|||
T19592-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Trimethoprim N-oxide |
Trimethoprim N-oxide |
|||
T19592-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trimethoprim N-oxide |
Trimethoprim N-oxide |
|||
T19592-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trimethoprim N-oxide |
Trimethoprim N-oxide |
|||
T19592-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trimethoprim N-oxide |
Trimethoprim 3-oxide |
|||
T19593-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Trimethoprim 3-oxide |
Trimethoprim 3-oxide |
|||
T19593-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Trimethoprim 3-oxide |
Trimethoprim 3-oxide |
|||
T19593-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trimethoprim 3-oxide |
Trimethoprim 3-oxide |
|||
T19593-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trimethoprim 3-oxide |
Trimethoprim 3-oxide |
|||
T19593-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trimethoprim 3-oxide |
Trimethoprim-d9 (Major) |
|||
T795617 | Toronto Research Chemicals | 10mg | EUR 236 |
Description: 1189460-62-5 |
Trimethoprim-d4 (Major) |
|||
T795623 | Toronto Research Chemicals | 10mg | EUR 374 |
Trimethoprim TR 5 mcg |
|||
SD039-1PK | EWC Diagnostics | 1 unit | EUR 6.31 |
Description: Trimethoprim TR 5 mcg |
Trimethoprim TR 5 mcg |
|||
SD039-1VL | EWC Diagnostics | 1 unit | EUR 2.99 |
Description: Trimethoprim TR 5 mcg |
Trimethoprim TR 5 mcg |
|||
SD039-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Trimethoprim TR 5 mcg |
Trimethoprim TR 5 mcg |
|||
SD039-5VL | EWC Diagnostics | 1 unit | EUR 11.84 |
Description: Trimethoprim TR 5 mcg |
Trimethoprim TR 5 mcg |
|||
SD039-5X50DS | EWC Diagnostics | 1 unit | EUR 6.5 |
Description: Trimethoprim TR 5 mcg |
Trimethoprim TR 10 mcg |
|||
SD093-1PK | EWC Diagnostics | 1 unit | EUR 6.31 |
Description: Trimethoprim TR 10 mcg |
Trimethoprim TR 10 mcg |
|||
SD093-1VL | EWC Diagnostics | 1 unit | EUR 2.99 |
Description: Trimethoprim TR 10 mcg |
Trimethoprim TR 10 mcg |
|||
SD093-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Trimethoprim TR 10 mcg |
Trimethoprim TR 10 mcg |
|||
SD093-5VL | EWC Diagnostics | 1 unit | EUR 11.84 |
Description: Trimethoprim TR 10 mcg |
Trimethoprim TR 10 mcg |
|||
SD093-5X50DS | EWC Diagnostics | 1 unit | EUR 6.5 |
Description: Trimethoprim TR 10 mcg |
Trimethoprim TR 25 mcg |
|||
SD148-1PK | EWC Diagnostics | 1 unit | EUR 6.31 |
Description: Trimethoprim TR 25 mcg |
Trimethoprim TR 25 mcg |
|||
SD148-1VL | EWC Diagnostics | 1 unit | EUR 2.99 |
Description: Trimethoprim TR 25 mcg |
Trimethoprim TR 25 mcg |
|||
SD148-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Trimethoprim TR 25 mcg |
Trimethoprim TR 25 mcg |
|||
SD148-5VL | EWC Diagnostics | 1 unit | EUR 11.84 |
Description: Trimethoprim TR 25 mcg |
Trimethoprim TR 25 mcg |
|||
SD148-5X50DS | EWC Diagnostics | 1 unit | EUR 6.5 |
Description: Trimethoprim TR 25 mcg |
Trimethoprim TR 30 mcg |
|||
SD149-1PK | EWC Diagnostics | 1 unit | EUR 6.31 |
Description: Trimethoprim TR 30 mcg |
Trimethoprim TR 30 mcg |
|||
SD149-1VL | EWC Diagnostics | 1 unit | EUR 2.99 |
Description: Trimethoprim TR 30 mcg |
Trimethoprim TR 30 mcg |
|||
SD149-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Trimethoprim TR 30 mcg |
Trimethoprim TR 30 mcg |
|||
SD149-5VL | EWC Diagnostics | 1 unit | EUR 11.84 |
Description: Trimethoprim TR 30 mcg |
Trimethoprim TR 30 mcg |
|||
SD149-5X50DS | EWC Diagnostics | 1 unit | EUR 6.5 |
Description: Trimethoprim TR 30 mcg |
Trimethoprim lactic acid |
|||
20-abx184460 | Abbexa |
|
|
4-Hydroxy Trimethoprim |
|||
H971980 | Toronto Research Chemicals | 10mg | EUR 265 |
Description: 112678-48-5 |
Trimethoprim Lactate Salt |
|||
42010018-1 | Glycomatrix | 250 mg | EUR 89.32 |
Trimethoprim Lactate Salt |
|||
42010018-2 | Glycomatrix | 1 g | EUR 181.19 |
Trimethoprim Lactate Salt |
|||
42010018-3 | Glycomatrix | 5 g | EUR 272.69 |
Trimethoprim lactate salt |
|||
GA5588-1 | Glentham Life Sciences | 1 | EUR 177.9 |
Trimethoprim lactate salt |
|||
GA5588-100 | Glentham Life Sciences | 100 | EUR 37.2 |
Trimethoprim lactate salt |
|||
GA5588-100MG | Glentham Life Sciences | 100 mg | EUR 80.4 |
Trimethoprim lactate salt |
|||
GA5588-1G | Glentham Life Sciences | 1 g | EUR 250.8 |
Trimethoprim lactate salt |
|||
GA5588-250 | Glentham Life Sciences | 250 | EUR 71.1 |
Trimethoprim lactate salt |
|||
GA5588-250MG | Glentham Life Sciences | 250 mg | EUR 122.4 |
Trimethoprim lactate salt |
|||
GA5588-500 | Glentham Life Sciences | 500 | EUR 102.7 |
Trimethoprim lactate salt |
|||
GA5588-500MG | Glentham Life Sciences | 500 mg | EUR 160.8 |
Trimethoprim Lactate Salt |
|||
T795628 | Toronto Research Chemicals | 250mg | EUR 437 |
Description: 23256-42-0 |
4-Hydroxy Trimethoprim-13C3 |
|||
H971981 | Toronto Research Chemicals | 10mg | EUR 242 |
3-Desmethyl Trimethoprim |
|||
D295705 | Toronto Research Chemicals | 100mg | EUR 230 |
Description: 27653-69-6 |
Trimethoprim (TMP) ELISA Kit |
|||
abx364830-96tests | Abbexa | 96 tests | EUR 1017.6 |
Trimethoprim (TMP) ELISA Kit |
|||
abx364833-96tests | Abbexa | 96 tests | EUR 1017.6 |
Trimethoprim (TMP) ELISA Kit |
|||
AE81051SF-48Tests | Abebio | 48 Tests | EUR 410 |
Description: Food Safety |
Trimethoprim (TMP) ELISA Kit |
|||
AE81051SF-96Tests | Abebio | 96 Tests | EUR 780 |
Description: Food Safety |
Trimethoprim (TMP) ELISA Kit |
|||
RDFS-TMP-48T | Reddot Biotech | 48T | EUR 488 |
Description: Tissue, feed, serum, plasma, urine, etc. |
Trimethoprim (TMP) ELISA Kit |
|||
RDFS-TMP-96T | Reddot Biotech | 96T | EUR 698 |
Description: Tissue, feed, serum, plasma, urine, etc. |
Trimethoprim 1-N-Oxide |
|||
T797535 | Toronto Research Chemicals | 10mg | EUR 187 |
Description: 27653-68-5 |
Trimethoprim 3-N-Oxide |
|||
T797545 | Toronto Research Chemicals | 10mg | EUR 187 |
Description: 27653-67-4 |
Trimethoprim (TMP) ELISA Kit |
|||
abx364830-100g | Abbexa | 100 µg | EUR 618.75 |
Trimethoprim (TMP) ELISA Kit |
|||
abx364833-100g | Abbexa | 100 µg | EUR 618.75 |
Trimethoprim (TMP) ELISA Kit |
|||
abx365111-100g | Abbexa | 100 µg | EUR 562.5 |
Trimethoprim Rapid Test Kit |
|||
100070 | Ring Biotechnology Co | 96T | EUR 100 |
Description: Milk Test |
Trimethoprim ELISA Test Kit |
|||
LSY-10065 | Shenzhen Lvshiyuan Biotechnology | 96 well/kit | Ask for price |
C-alpha-NAC Trimethoprim |
|||
T795614 | Toronto Research Chemicals | 5mg | EUR 1800 |
4-Hydroxy Trimethoprim-d9 |
|||
H971982 | Toronto Research Chemicals | 10mg | EUR 201 |
Description: 1794752-40-1 |
Trimethoprim rapid test strip |
|||
LSY-20114 | Shenzhen Lvshiyuan Biotechnology | 96 test/kit | Ask for price |
3-Desmethyl Trimethoprim-d3 |
|||
D295706 | Toronto Research Chemicals | 50mg | EUR 7600 |
Trimethoprim ReadyMadeTM Solution |
|||
T144-10x1ML | TOKU-E | 10 x 1 ml | EUR 274.46 |
Description: C14H18N4O4 |
Trimethoprim ReadyMadeTM Solution |
|||
T144-1ML | TOKU-E | 1 ml | EUR 38.44 |
Description: C14H18N4O3 |
a-Hydroxy Trimethoprim (Impurity) |
|||
H971985 | Toronto Research Chemicals | 250mg | EUR 221 |
Description: 29606-06-2 |
N2-Methyl Trimethoprim (Impurity) |
|||
M331190 | Toronto Research Chemicals | 100mg | EUR 221 |
Description: 213745-86-9 |
Meat Trimethoprim Rapid Test Kit |
|||
510034 | Ring Biotechnology Co | 48T | EUR 96 |
Description: Meat Test |
Conclusions: Strategies for the prevention of individualized infections adapted to the operative level are necessary in the surgery of the spine. Endogenous contamination of the wound with an enteric flora can be a common mechanism of infection in the bulging melting. New approaches to prophylaxis and prevention should be priorities in this population.